
UBT Srl is an innovative biomedical technology company pioneering microwave imaging for diagnostic medical devices. Founded in 2015 as an academic spin-off from the University of Perugia, Italy, UBT develops patented, radiation-free imaging devices such as MammoWave and BrainWave. MammoWave is a CE-marked, patented microwave imaging device for breast lesion detection, offering a safe, accurate, and comfortable alternative to traditional mammography without ionizing radiation or breast compression. It is enhanced by AI algorithms and clinically validated through multicenter trials across Europe. UBT operates as a Benefit Company with subsidiaries in Italy and the UK, participating in major European research projects including Horizon 2020 and Horizon Europe. Their business model is primarily based on selling medical devices to hospitals and clinics, aiming to transform cancer screening with safer, inclusive, and more accessible technologies.

UBT Srl is an innovative biomedical technology company pioneering microwave imaging for diagnostic medical devices. Founded in 2015 as an academic spin-off from the University of Perugia, Italy, UBT develops patented, radiation-free imaging devices such as MammoWave and BrainWave. MammoWave is a CE-marked, patented microwave imaging device for breast lesion detection, offering a safe, accurate, and comfortable alternative to traditional mammography without ionizing radiation or breast compression. It is enhanced by AI algorithms and clinically validated through multicenter trials across Europe. UBT operates as a Benefit Company with subsidiaries in Italy and the UK, participating in major European research projects including Horizon 2020 and Horizon Europe. Their business model is primarily based on selling medical devices to hospitals and clinics, aiming to transform cancer screening with safer, inclusive, and more accessible technologies.